title: Thyroid hormone is required for growth adaptation to pressure load in the ovine fetal heart.
abstract: Thyroid hormone exerts broad effects on the adult heart, but little is known regarding the role of thyroid hormone in the regulation of cardiac growth early in development and in response to pathophysiological conditions. To address this issue, we determined the effects of fetal thyroidectomy on cardiac growth and growth-related gene expression in control and pulmonary-artery-banded fetal sheep. Fetal thyroidectomy (THX) and/or placement of a restrictive pulmonary artery band (PAB) were performed at 126 ± 1 days of gestation (term, 145 days). Four groups of animals [n = 5-6 in each group; (i) control; (ii) fetal THX; (iii) fetal PAB; and (iv) fetal PAB + THX] were monitored for 1 week prior to being killed. Fetal heart rate was significantly lower in the two THX groups compared with the non-THX groups, while mean arterial blood pressure was similar among groups. Combined left and right ventricle free wall + septum weight, expressed per kilogram of fetal weight, was significantly increased in PAB (6.27 ± 0.85 g kg(-1)) compared with control animals (4.72 ± 0.12 g kg(-1)). Thyroidectomy significantly attenuated the increase in cardiac mass associated with PAB (4.94 ± 0.13 g kg(-1)), while THX alone had no detectable effect on heart mass (4.95 ± 0.27 g kg(-1)). The percentage of binucleated cardiomyocytes was significantly decreased in THX and PAB +THX groups (∼16%) compared with the non-THX groups (∼27%). No differences in levels of activated Akt, extracellular signal-regulated kinase or c-Jun N-terminal kinase were detected among the groups. Markers of cellular proliferation but not apoptosis or expression of growth-related genes were lower in the THX and THX+ PAB groups relative to thyroid-intact animals. These findings suggest that in the late-gestation fetal heart, thyroid hormone has important cellular growth functions in both physiological and pathophysiological states. Specifically, thyroid hormone is required for adaptive fetal cardiac growth in response to pressure overload.
authors.affiliation: Department of Pediatrics, University of Iowa Carver College of Medicine, University of Iowa Children's Hospital, 200 Hawkins Drive, Iowa City, IA 52242, USA. jeffrey-segar@uiowa.edu
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Segar
authors.forename: Ken A
authors.initials: KA
authors.lastname: Volk
authors.forename: Michael H B
authors.initials: MH
authors.lastname: Lipman
authors.forename: Thomas D
authors.initials: TD
authors.lastname: Scholz
mesh_terms: D000818:Animals; D002467:Cell Nucleus; D003250:Constriction; D005260:Female; D047109:Fetal Development / Q000187:drug effects*; D005318:Fetal Heart / Q000196:embryology* / Q000378:metabolism / Q000502:physiology; D006339:Heart Rate; D006352:Heart Ventricles / Q000196:embryology* / Q000378:metabolism; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000648:ultrastructure; D011247:Pregnancy; D011312:Pressure / Q000009:adverse effects*; D011651:Pulmonary Artery / Q000502:physiology; D034561:Sheep, Domestic; D013963:Thyroid Hormones / Q000502:physiology*; D013965:Thyroidectomy
chemical_list: D013963:Thyroid Hormones